Slide 1: Cochlear Limited 2016 Annual General Meeting
10/17/2016 For personal use only Cochlear Limited 2016 Annual General Meeting 18th October 2016 Cochlear Limited 2016 Annual General Meeting Rick Holliday-Smith Chairman 1
Slide 2: Chairman and Company Secretary
10/17/2016 Rick Holliday-Smith Chairman For personal use only 3 Neville Mitchell Company Secretary 4 2
Slide 3: CEO and Director
10/17/2016 Chris Smith Chief Executive Officer & President For personal use only 5 Professor Ed Byrne, AC Director 6 3
Slide 4: Directors Yasmin Allen and Glen Boreham
10/17/2016 Yasmin Allen Director For personal use only 7 Glen Boreham AM Director 8 4
Slide 5: Directors Alison Deans and Donal O’Dwyer
10/17/2016 Alison Deans Director For personal use only 9 Donal O’Dwyer Director 10 5
Slide 6: Director Andy Denver
10/17/2016 Andy Denver Director For personal use only 11 Cochlear Limited 2016 Annual General Meeting 18th October 2016 6
Slide 7: FY16 – Result highlights and FY17 outlook
10/17/2016 FY16 – Result highlights For personal use only Sales revenue 23% (12% in CC) to $1.2 billion • Growth across developed and emerging markets • Cochlear implant unit growth 12% and CI sales revenue 21% (10% in CC) • Services sales revenue 30% (20% in CC) • Acoustics sales revenue
Slide 8: Shareholder reports
10/17/2016 Shareholder reports For personal use only 15 Cochlear Limited 2016 Annual General Meeting Chris Smith Chief Executive Officer & President 8
Slide 9: Neville Mitchell – Chief Financial Officer
10/17/2016 Neville Mitchell – Chief Financial Officer For personal use only 26 year contribution to Cochlear’s global success • Part of the team that floated Cochlear in 1995 with a marketcap of $125m • Key driver of the successful and consistent long-term growth strategy that has seen Cochlear grow
Slide 10: Hearing loss market opportunity
10/17/2016 Hearing loss market opportunity For personal use only Cochlear’s vision is to make implantable hearing solutions the standard of care for people with severe to profound hearing loss. 1. Deafness and hearing loss [Internet]. World Health Organization. 2016 [cited 26 April 2016]. Available
Slide 11: Strategic platforms; Grow the Core
10/17/2016 Strategic platforms For personal use only Grow Build a Service the Core Business Shape the Customer Value Organisation Creation Focus 21 Grow the Core • Introduced new products to continue market leadership Nucleus Slim Modiolar (CI532) Kanso electrode Mini mic 2+ Cochlear Link Baha 5 Pow
Slide 12: Grow the Core
10/17/2016 For personal use only Grow the Core • Introduced new products to continue market leadership • Expanded direct to Nucleus Slim Modiolar (CI532) consumer programs Kanso electrode • Expanded the sales force Mini mic 2+ Cochlear Link Baha 5 Power Baha 5 SuperPower Service Business • Establish
Slide 13: Shape the Organisation
10/17/2016 For personal use only Shape the Organisation • Enhanced leadership capabilities Malaysia Operations • Global alignment of enabling activities • Established “One Cochlear” operating model Value Creation • Strengthened the Smart Hearing Alliance • Established an innovation fund 13
Slide 14: The Future is Wireless
10/17/2016 For personal use only Cochlear Limited 2016 Annual General Meeting Jan Janssen Senior Vice President, Design & Development The Future is Wireless Phone Music Nucleus 6 Sound Processor Control Baha 5 Status Sound Processor MiniMic 2 MiniMic 2+ Nucleus 6 True Wireless accessories 28 28 14
Slide 15: The Future is Connected – Cochlear Link
10/17/2016 The Future is Connected – Cochlear Link For personal use only 29 The Future is Wireless – also for Clinicians CONVENIENT No equipment or PC setup required FAST No setup time and faster measures SIMPLE One button diagnostics for less training Portable wireless fast cochlear implant diagnos
Slide 16: The Future preserves more Residual Hearing; Binaural
10/17/2016 The Future preserves even more Residual Hearing For personal use only Nucleus Profile implant with Slim Straight electrode Atraumatic electrode insertion Research drug (cochlea cross-section) eluting electrode 31 The Future is Binaural Bimodal Bilateral Cochlear Implants True Wireless for
Slide 17: The Future supports different customer segments
10/17/2016 The Future supports different customer segments For personal use only “I love the fact that I don’t have to “I want to take control of my hearing care about my device” loss and excel at every stage of my life” Out and Proud Excel It’s about Simplicity It’s all about my life the device “I
Slide 18: Resolution 1.1 Financial and other reports
10/17/2016 Resolution 1.1 For personal use only Financial and other reports To receive and consider the Company’s Financial Report, Directors’ Report and the Auditor’s Report in respect of the financial year ended 30 June 2016 and to consider and, if thought fit, to pass the following resolution: 1.
Slide 19: Resolution 2.1 Remuneration Report
10/17/2016 Resolution 2.1 For personal use only Remuneration Report To consider and, if thought fit, to pass the following non-binding resolution: 2.1 “THAT the Remuneration Report in respect of the financial year ended 30 June 2016 be adopted.” 37 Resolution 2.1 Remuneration Report Proxies have bee
Slide 20: Resolution 3.1 Re-election of Yasmin Allen
10/17/2016 Resolution 3.1 For personal use only Re-election of directors – Yasmin Allen 3.1 “THAT Yasmin Allen, being a director who is retiring in accordance with the Company’s Constitution and who, being eligible, offers herself for re-election as a director of the Company, be re-elected as a dire
Slide 21: Resolution 3.2 Re-election of Donal O’Dwyer
10/17/2016 Resolution 3.2 For personal use only Re-election of directors – Donal O’Dwyer 3.2 “THAT Donal O’Dwyer, being a director who is retiring in accordance with the Company’s Constitution and who, being eligible, offers himself for re-election as a director of the Company, be re-elected as a di
Slide 22: Resolution 4.1 Securities to CEO under CEIP
10/17/2016 Resolution 4.1 For personal use only Approval of securities to be granted to the Chief Executive Officer & President under the Cochlear Executive Incentive Plan (CEIP) To consider and, if thought fit, to pass the following resolution as an ordinary resolution: 4.1 “THAT approval be given
Slide 23: Disclaimer – Non-IFRS financial measures
10/17/2016 For personal use only Cochlear Limited 2016 Annual General Meeting 18th October 2016 Disclaimer Non-IFRS financial measures Given the significance of the patent dispute and FX movements the directors believe the presentation of non-IFRS financial measures is useful for the users of this d